ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,163,078 | -62.0% | 512,369 | -27.1% | 0.00% | -100.0% |
| Q2 2023 | $3,064,444 | +23.6% | 702,854 | +26.1% | 0.00% | 0.0% |
| Q1 2023 | $2,479,420 | +891777.7% | 557,173 | +1585.3% | 0.00% | – |
| Q4 2022 | $278 | -99.9% | 33,060 | +0.1% | 0.00% | – |
| Q3 2022 | $202,000 | +102.0% | 33,032 | +2.3% | 0.00% | – |
| Q2 2022 | $100,000 | -50.0% | 32,297 | -8.1% | 0.00% | – |
| Q1 2022 | $200,000 | -56.1% | 35,127 | -24.6% | 0.00% | – |
| Q4 2021 | $456,000 | -90.9% | 46,596 | -1.9% | 0.00% | -100.0% |
| Q3 2021 | $5,027,000 | +0.5% | 47,481 | -18.9% | 0.00% | 0.0% |
| Q2 2021 | $5,000,000 | -28.2% | 58,568 | -3.4% | 0.00% | 0.0% |
| Q1 2021 | $6,960,000 | +94.7% | 60,634 | +137.5% | 0.00% | +100.0% |
| Q4 2020 | $3,574,000 | +129.0% | 25,530 | +33.2% | 0.00% | 0.0% |
| Q3 2020 | $1,561,000 | +95.6% | 19,163 | +72.6% | 0.00% | – |
| Q2 2020 | $798,000 | +46.4% | 11,100 | -9.4% | 0.00% | – |
| Q1 2020 | $545,000 | -69.3% | 12,252 | -34.3% | 0.00% | -100.0% |
| Q4 2019 | $1,778,000 | +67.9% | 18,646 | +38.5% | 0.00% | – |
| Q3 2019 | $1,059,000 | – | 13,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,268,188 | $184,744,000 | 7.82% |
| Fairmount Funds Management LLC | 164,662 | $13,412,000 | 5.68% |
| Samsara BioCapital, LLC | 192,334 | $15,666,000 | 4.37% |
| Redmile Group, LLC | 2,425,560 | $197,562,000 | 3.63% |
| Boxer Capital, LLC | 675,000 | $54,979,000 | 1.90% |
| Rock Springs Capital Management LP | 241,582 | $19,677,000 | 0.50% |
| Handelsinvest Investeringsforvaltning | 30,000 | $2,444,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $1,279,000 | 0.41% |
| Eventide Asset Management | 160,000 | $13,032,000 | 0.26% |
| Cormorant Asset Management, LP | 75,000 | $6,109,000 | 0.24% |